Citadel Advisors’s Absci ABSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$505K Sell
168,200
-108,200
-39% -$313K ﹤0.01% 9285
2025
Q4
$965K Buy
276,400
+193,500
+233% +$705K ﹤0.01% 7473
2025
Q3
$252K Buy
82,900
+14,100
+20% +$39K ﹤0.01% 10738
2025
Q2
$177K Sell
68,800
-38,000
-36% -$107K ﹤0.01% 10795
2025
Q1
$268K Buy
106,800
+33,000
+45% +$121K ﹤0.01% 9839
2024
Q4
$193K Buy
73,800
+7,200
+11% +$25.3K ﹤0.01% 10516
2024
Q3
$254K Buy
66,600
+46,000
+223% +$183K ﹤0.01% 9639
2024
Q2
$63.4K Sell
20,600
-7,400
-26% -$34.3K ﹤0.01% 11500
2024
Q1
$159K Sell
28,000
-36,600
-57% -$165K ﹤0.01% 10675
2023
Q4
$271K Buy
64,600
+59,200
+1,096% +$110K ﹤0.01% 9349
2023
Q3
$7.13K Sell
5,400
-14,300
-73% -$25K ﹤0.01% 13278
2023
Q2
$29.9K Sell
19,700
-4,900
-20% -$7.88K ﹤0.01% 12352
2023
Q1
$43K Buy
24,600
+18,100
+278% +$43.8K ﹤0.01% 12357
2022
Q4
$13.7K Sell
6,500
-21,900
-77% -$59.9K ﹤0.01% 13431
2022
Q3
$89K Buy
+28,400
New +$104K ﹤0.01% 11177

Other funds holding ABSI

Citadel Advisors's ABSI Position: Q1 2026 in Review

Citadel Advisors reduced its Absci (ABSI) stake by 79% in Q1 2026, selling an estimated $4.46M and leaving 404,423 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #7231.

Citadel Advisors first reported a position in ABSI in Q3 2021 and has held it in 17 quarters since. The position peaked at $6.78M in Q4 2025. 164 funds tracked by Wall St. Rank hold ABSI as of Q1 2026.

  • Citadel Advisors held 404,423 shares of Absci worth $1.21M as of Q1 2026.
  • Citadel Advisors sold 1,539,213 Absci shares in Q1 2026, an estimated $4.46M.
  • Absci made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7231 holding.
  • Citadel Advisors first reported a position in Absci in Q3 2021 and has held it in 17 quarters since.
  • Citadel Advisors's Absci position peaked at $6.78M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Absci as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.